An interventional study of Nebivolol and Metoprolol in Central Aortic Pressure, sponsored by Creighton University. Withdrawn at 1 site in United States. Open to participants aged 45 Years to 75 Years. Per ClinicalTrials.gov, last updated 2011-08-01.
Sponsored by Creighton University · Not applicable, Interventional, and Treatment
A randomized, cross-over, single-blind study to compare the effects of nebivolol and metoprolol on central aortic pressure and peripheral brachial pressure in patients with stable cardiovascular disease.
Creighton University is the lead sponsor of 126 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Nebivolol therapy for 2-6 weeks depending on blood pressure readings
Drug: Nebivolol
Metoprolol therapy for 2-6 weeks depending on blood pressure readings
Drug: Metoprolol
10 mg by mouth daily for 2 weeks 20 mg by mouth daily for 2 weeks 40 mg by mouth daily for 2 weeks
dosage prescribed prior to starting on study
Stable blood pressure
Subjects will be randomized to nebivolol or metoprolol. Their medication will be titrated so that their blood pressure is within 10% of their initial reading.
Time frame: 6 months
This study is withdrawn, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Creighton University